Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)

Launched by ALL NATURAL MEDICINE CLINIC, LLC · Mar 9, 2021

Keywords

ClinConnect Summary

This clinical trial is investigating whether certain medical herbs can help the immune system fight off the COVID-19 virus without causing harmful side effects. When COVID-19 infects a person, it can trigger an overwhelming immune response known as a cytokine storm, which can lead to serious organ damage. The researchers believe that by using these natural medicines, they can calm the immune response and help the body effectively target and eliminate the virus. The trial aims to show how these herbs can retrain the immune system to handle infections better.

To participate in this study, individuals must be diagnosed with COVID-19 within the last 1 to 20 days and be between the ages of 10 and 70. Both those who have received standard medical treatment and those who have not can join. Participants will need to provide certain medical information and undergo evaluations throughout the study. This trial is open to all genders and backgrounds, and it seeks to explore the healing potential of medical herbs that have been used for centuries. Participants can expect to take herbal treatments and undergo health assessments to see how well the herbs work.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• A subject will be eligible for inclusion in this study if any of the following criteria apply:
• • Individuals diagnosed with COVID-19 virus infection in the past 1-20 days must submit the proved metrics of COVID-19 virus marks positive during the registration;
• • The age of participants is between 10-70 years old;
• • The participants are received or not received conventional medication treatment, and continuing the treatment patients, could be enrolled in this clinical study;
• • This clinical study is not restricted to gender, age, sex, race, and nationality;
• • The participants must have reports of CBC, C3, C4, IgM, IgG, CD4/CD8, and lungs' images ready before the clinical study;
• • The Participants must repeat the evaluation experiment during and at the end of the clinical study.
• Exclusion Criteria:
• A subject will not be eligible for inclusion in this study if any of the following criteria apply:
• • Individuals with a prior COVID-19 virus infection that no longer shows up from COVID-19 testing;
• • Children who are younger than 10-year-old, cannot control themselves to take the medical herbs on time;
• • Elders whose age beyond 70-year-old, with severe underline illness;
• • COVID-19 virus-infected patients who do not feel willing to take medical herbs;
• • Patients diagnosed with COVID-19 virus infection cannot consistently finish the treatment courses for a specific reason;
• • Patients diagnosed with COVID-19 virus infection but do not willing to share their information with the public;
• • Current or past participation within a specified timeframe in another clinical trial, as warranted by this intervention's administration;
• • Severe patients, when there have insufficient normal cells, can be adjusted, with pre-list diseases life-threatening.